98-C-0074 A Phase II Study of Intravenous RMP-7 and Carboplatin in Childhood Brain Tumors

Principal Investigator: Dr. Katherine Warren

01-C-0222: A Phase II Randomized, Cross-Over, Double-Blinded, Placebo-Controlled Trial of the Farnesyltransferase Inhibitor R115777 in Pediatric Patients with Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Principal Investigator: Dr.Brigitte Widemann

01-C-0030: Short-Course EPOCH-Rituximab for Untreated CD-20+
HIV-Associated Lymphomas

Principal Investigator: Alan Wayne

04-C-0173: Phase II Study Of UCN-01 In Relapsed Or Refractory Systemic Anaplastic Large Cell And Mature T-Cell Lymphomas

Principal Investigator: Alan Wayne

Also see Pharmacology and Experimental Therapeutics Section

Last Updated: October 3, 2006

NCI Home Page|| NIH Home Page

© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute